Nasdaq · Healthcare
COOPER COMPANIES, INC. (COO)
As-reported financials and recent SEC filings for COOPER COMPANIES, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$4.09B
Net income
$374.9M
Net margin
9.2%
Diluted EPS
$1.87
ROE
4.6%
P/E (TTM)
60.2×
Market cap
$13.85B
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B |
| Gross profit | $2.68B | $2.60B | $2.36B | $2.14B | $1.96B |
| Operating income | $682.9M | $705.7M | $533.1M | $507.6M | $505.8M |
| Net income | $374.9M | $392.3M | $294.2M | $385.8M | $2.94B |
| Diluted EPS | $1.87 | $1.96 | $1.48 | $1.94 | $14.79 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
10-Q2026-06-05
View on EDGAR →8-K2026-06-04
View on EDGAR →SD2026-05-29
View on EDGAR →SCHEDULE 13G/A2026-05-14
View on EDGAR →8-K2026-05-04
View on EDGAR →SCHEDULE 13G2026-04-29
View on EDGAR →42026-04-21
View on EDGAR →8-K2026-04-08
View on EDGAR →Go deeper on COO
Search COOPER COMPANIES, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.